Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Screening Study of Patient Eligibility for Participation in National Cancer Institute Radiation Therapy Clinical Trials
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), November 2008
Sponsored by: National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00020280
  Purpose

RATIONALE: Screening tests may help doctors determine which patients are eligible for treatment on clinical trials.

PURPOSE: Screening trial to determine whether patients are eligible to participate in National Cancer Institute radiation therapy clinical trials.


Condition Intervention
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific
Procedure: physiologic testing

MedlinePlus related topics: Cancer
U.S. FDA Resources
Study Type: Interventional
Study Design: Screening
Official Title: Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Evaluation of patients referred to the NCI Radiation Oncology Branch during screening to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols [ Designated as safety issue: No ]

Estimated Enrollment: 1000
Study Start Date: July 2000
Estimated Primary Completion Date: July 2025 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

  • Evaluate patient eligibility for participation in NCI Radiation Oncology Branch protocols.
  • Permit standard therapy for patients ineligible for active Radiation Oncology Branch protocols who present a novel or unique clinical training opportunity or who present conditions requiring immediate intervention in order to avoid compromising patient's health.

OUTLINE: Patients undergo various diagnostic procedures and clinical testing to determine protocol eligibility. The testing and procedures may include hepatitis screen; HIV serology; MRI, CT, and PET scans; pulmonary function tests; arteriogram; tumor biopsy; and laparoscopy.

PROJECTED ACCRUAL: A total of 1,000 patients will be accrued for this study within 5 years.

  Eligibility

Ages Eligible for Study:   1 Year and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Histologically proven or suspected malignant disease or benign condition for which radiotherapy is a potential treatment

PATIENT CHARACTERISTICS:

Age

  • 1 and over

Performance status

  • Not specified

Life expectancy

  • Not specified

Hematopoietic

  • Not specified

Hepatic

  • Not specified

Renal

  • Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy

  • Not specified

Chemotherapy

  • Not specified

Endocrine therapy

  • Not specified

Radiotherapy

  • Not specified

Surgery

  • Not specified

Other

  • No concurrent therapy unless ineligible for Radiation Oncology Branch protocol and standard therapy deemed to be in the best interest of patient and suitable for training needs of Radiation Oncology Branch staff
  • No concurrent participation in other research protocol
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00020280

Locations
United States, Maryland
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Recruiting
Bethesda, Maryland, United States, 20892-1182
Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center     888-NCI-1937        
Sponsors and Collaborators
Investigators
Principal Investigator: Kevin Camphausen, MD NCI - Radiation Oncology Branch; ROB
  More Information

Clinical trial summary from the National Cancer Institute's PDQ® database  This link exits the ClinicalTrials.gov site

Study ID Numbers: CDR0000068200, NCI-00-C-0181
Study First Received: July 11, 2001
Last Updated: December 11, 2008
ClinicalTrials.gov Identifier: NCT00020280  
Health Authority: Unspecified

Keywords provided by National Cancer Institute (NCI):
unspecified childhood solid tumor, protocol specific
unspecified adult solid tumor, protocol specific

ClinicalTrials.gov processed this record on January 14, 2009